韩国罕见血管疾病研究专家组关于腘动脉陷迫综合征长期治疗结局的研究
韩国14家三级医疗中心回顾性收集2003至2023年腘动脉陷迫综合征(PAES)数据,分析96例患者111条肢体的侵入性治疗结局;单纯肌肌腱切断术组长期一期通畅率优良,PTFE移植物旁路术是通畅率丧失的显著危险因素,应避免使用。
要点
- 早期PAES仅行肌肌腱切断术者长期一期通畅率优良。
- 需动脉重建时,肌肌腱切断联合原位血运重建与旁路术长期通畅率相当。
- PTFE移植物旁路术是通畅率丧失的显著危险因素,应避免使用。
核心结论
- 早期PAES仅行肌肌腱切断术者长期一期通畅率优良;需动脉重建时,肌肌腱切断联合原位血运重建与旁路术长期一期通畅率相当;但PTFE移植物旁路术因闭塞风险高应避免使用。
研究设计与样本
- 韩国罕见血管疾病研究专家组开展全国性回顾性数据收集,纳入2003至2023年14家三级医疗中心96例患者111条肢体的侵入性治疗数据。
主要发现
- 患者中位年龄37.5岁(范围14-82岁),男性占92.8%;81%表现为间歇性跛行,13.5%为静息痛;腘动脉狭窄占24.3%,闭塞占75.6%。
- 共行109例开放手术和2例血管内治疗。
- 单纯肌肌腱切断术组(n=25)1、5、9年一期通畅率分别为94.7%、94.7%、94.7%。
- 肌肌腱切断联合原位血运重建组(n=55)1、5、9年一期通畅率分别为90.1%、77.0%、77.0%。
- 旁路手术组(n=29)1、5、9年一期通畅率分别为88.6%、82.7%、68.9%。
临床怎么用
- 作者认为,早期PAES仅行肌肌腱切断术可获得优良的长期一期通畅率。
- 作者认为,需动脉重建时肌肌腱切断联合原位血运重建与旁路术长期一期通畅率相当。
- 作者建议避免使用PTFE移植物旁路术,因其闭塞风险高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Popliteal artery entrapment syndrome (PAES) results from an anomalous relationship between the popliteal artery and the myofascial structures of the popliteal fossa. The long-term treatment outcomes are not well-known because of the rarity of the disease. This study aimed to establish a nationwide collective dataset and analyze treatment outcomes. MATERIALS AND METHODS: The Korean Rare Vascular Ailment Research Experts performed nationwide retrospective data collection on PAES from 2003 to 2023. Fourteen tertiary medical centers participated, and data from 111 limbs of 96 patients who received invasive treatment with sufficient baseline and follow-up data were used for statistical analysis. RESULTS: The median age was 37.5 years (range, 14-82 years), and 92.8% were male. Eighty-one percent of the patients presented with claudication, and 13.5% with rest pain. The popliteal arteries were stenotic in 24.3% and occluded in 75.6%. A total of 109 open surgeries and two endovascular treatments were performed. The primary patency rates at 1, 5, and 9 years were compared according to the surgery type: musculotendinous section (MTS) only group (n = 25), 94.7%, 94.7%, and 94.7%; MTS with in situ revascularization group (n = 55), 90.1%, 77.0%, and 77.0%; and bypass surgery group (n = 29), 88.6%, 82.7%, and 68.9%, respectively. In multivariate analysis for the loss of primary patency, bypass using PTFE graft (hazard ratio, 9.676; 95% confidence interval, 1.032-90.736; P = .047) was a statistically significant risk factor. CONCLUSION: Patients with early-stage PAES treated with MTS alone showed excellent long-term primary patency. When arterial reconstruction was needed in PAES, MTS with in situ revascularization and bypass surgery showed comparable long-term primary patency. However, bypass surgery using PTFE graft should be avoided due to the high risk of occlusion.
引用
- Roh YN, Woo HY, Kim DI, et al. Long-term treatment outcomes of popliteal artery entrapment syndrome by the Korean Rare Vascular Ailment Research Experts. J Vasc Surg. 2024. PMID: 39694155. doi:10.1016/j.jvs.2024.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。